EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN.

MLA

Terasaki, Hiroko, et al. “Efficacy and Safety Outcomes of Intravitreal Aflibercept Focusing on Patients with Diabetic Macular Edema from Japan.” Retina (Philadelphia, Pa.), vol. 39, no. 5, May 2019, pp. 938–47. EBSCOhost, https://doi.org/10.1097/IAE.0000000000002100.

APA

Terasaki, H., Shiraki, K., Ohji, M., Metzig, C., Schmelter, T., Zeitz, O., Sowade, O., Kobayashi, M., Vitti, R., Berliner, A., & Shiraga, F. (2019). Efficacy and Safety Outcomes of Intravitreal Aflibercept Focusing on Patients with Diabetic Macular Edema from Japan. Retina (Philadelphia, Pa.), 39(5), 938–947. https://doi.org/10.1097/IAE.0000000000002100

Chicago

Terasaki, Hiroko, Kunihiko Shiraki, Masahito Ohji, Carola Metzig, Thomas Schmelter, Oliver Zeitz, Olaf Sowade, et al. 2019. “Efficacy and Safety Outcomes of Intravitreal Aflibercept Focusing on Patients with Diabetic Macular Edema from Japan.” Retina (Philadelphia, Pa.) 39 (5): 938–47. doi:10.1097/IAE.0000000000002100.